Table 1.
Tumor type | Cell lines | Key signaling | References |
---|---|---|---|
Leukemia | HL-60 | Caspase-3↑, Bcl-2↓, telomerase activity↓ | 14 |
Caspase-3↑, H2AX phosphorylation, cleavage of PARP | 15, 16 | ||
NALM-6 | VEGF, cMyc, NF-κB↓ | 18 | |
Multiple myeloma | 8226 | ABCG2 protein↓, Akt1 protein↓ | 19, 20 |
HCC | HepG2 | Bcl-2↓, Bax protein↑, pro-caspase-3↑ | 24 |
ROS, ER stress | 24 | ||
Nrf2↓ | 24 | ||
SMMC-7721 | PI3K/AKT↓, Bax↑, Bcl-2↓, caspase-3↑, p21 | 24 | |
CRC | HCT116 | HIF-1α↓, PI3K/AKT↓ | 29 |
G1 arrest, Wnt/β-catenin↓ | 30 | ||
HT-29 | NF-κB, Nrf2, AKT | 27, 31, 32 | |
Breast cancer | MCF-7 | PI3K/AKT↓ | 11, 36–38 |
ERK↑, p38 MAPKs↑, HIF-1α↑ | 39 | ||
MDA-MB-231 | PKCδ↓, ERK phosphorylation, MMP-9↓ | 40 | |
Glioma | F98 | AKT↓, GSK-3β↓, NF-κB↓ | 47 |
C6 and U251 | G1 arrest, GSK-3β↓, AKT↓ | 48 | |
GBM8401 | PKCα, ERK, NF-κB, MMP-9 | 49 | |
U87 and U251 | ROS, ER stress | 50, 51, 53 | |
U87-MG, U343-MG, U373, T98G, and MCF-10A | AMPK, p53 | 52 | |
Lung cancer | A549 | p53↑, Bax↑ | 55 |
ROS | 56 | ||
IL-6/STAT3 | 57 | ||
COX-2↓, c-Jun↓, AP-1↓ | 58 | ||
SK-MES-1 | p53↑, Bax↑, Cyclin D1 | 55 | |
Cervical cancer | HeLa | p53, p21Cip1 | 59 |
HPV-16 | E6↓, E7↓ | 60 | |
Nasopharyngeal carcinoma | NPC-TW076/039 | GSK-3β↓, ΔNp63↓ | 61 |
mTOR/P70S6K, AKT, Raf/ERK | 62 | ||
Osteosarcoma | U-2 OS | ER stress | 63 |
Melanoma | B60-F10 | Extracellular regulated protein kinases and protein kinase B | 64 |
Abbreviations: HCC, hepatocellular carcinoma; CRC, colorectal cancer; WG, wogonin; ROS, reactive oxygen species; ER, endoplasmic reticulum; Nrf2, NF-E2-related factor 2; ERK, extracellular signal-regulated kinase.